Just before the 23andMe SPAC deal closed, the stock belonging to its merger ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder ...

23andMe, the company whose mail-in self-testing ... there's no legal obligation to ensure customer privacy under another owner. The risks, Caplan said, is that the data could be used in ways ...

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Despite the bankruptcy filing, 23andMe assures that its data storage and protection protocols remain unchanged. However, privacy experts advise users to delete their data due to potential risks of ...

Genetic analysis company 23andMe (ME) announced this week it's declaring bankruptcy and pursuing a sale, leading many customers to pursue deleting their data from the company. 23andMe was founded ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...